Follow us: |
The Recruitment of Systemic-to-Pulmonary Arterial Collaterals in Chronic and Severe Precapillary Pulmonary Hypertension as an Adaptive or Misguided Mechanism
1Department of Cardiology, Başkent University, İstanbul Hospital, İstanbul, Türkiye
2Department of Cardiology, Kartal Koşuyolu Training and Research Hospital, İstanbul, Türkiye
3Department of Cardiology, Tunceli State Hospital, Tunceli, Türkiye
4Department of Cardiology, Çukurova University, Faculty of Medicine, Adana, Türkiye
5Department of Cardiology, Medipol University, Faculty of Medicine, İstanbul, Türkiye
6Department of Cardiology, Yalova State Hospital, Yalova, Türkiye
7MEDMAR Imaging Center, İstanbul, Türkiye
8Department of Cardiology and Biostatistics, Atlas University, Faculty of Medicine, İstanbul, Türkiye
Anatol J Cardiol - PubMed ID: 43042572 DOI: 10.14744/AnatolJCardiol.2026.6587
Full Text PDF

Abstract

Background: The clinical impact of systemic-to-pulmonary arterial collaterals (SPCs) across pulmonary hypertension (PH) groups remains unclear. The authors evaluated the prevalence, clinical correlates, and prognostic relevance of SPCs in a comprehensive PH cohort.

Methods: The authors retrospectively analyzed 434 adult PH patients diagnosed per European Society of Cardiology and European Respiratory Society (ESC/ERS) guidelines. Baseline risk was evaluated using multiparametric risk scores. All patients underwent diagnostic heart catheterization and angiography, with SPC recruitment semi-quantitatively graded from 0 (none) to 3 (severe, high grade: 2-3).

Results: Mean age was 51.9 ± 18.2 years (61.1% female; groups 1, 2, 3, and 4 comprised 51.6%, 3.4%, 10.1%, and 33.2%, respectively). High-grade SPCs were significantly more prevalent in group 4 (58.3%) compared to groups 1 (30.4%), 2 (20.0%), and 3 (6.8%) (P <.001). Higher SPC grade significantly correlated with PH severity across clinical, echocardiographic, hemodynamic, and risk score measures (P <.001). Although higher SPC grades were linked to clinical worsening requiring parenteral prostacyclins (P = .027), they were not associated with overall 5-year survival, regardless of pulmonary vascular resistance severity or non-CTEPH etiology (P = .920). Only the Registry to Evaluate Early and Long-Term PAH Disease Management 2.0 score independently predicted mortality (hazard ratio [HR] = 1.19, P <.001, 95% CI: 1.13-1.26).

Conclusion: Systemic-to-pulmonary arterial collaterals are recruited across all PH etiology groups beyond group 4. While SPC recruitment serves as a marker of advanced pulmonary vascular involvement and elevated risk status, it does not act as an independent driver of long-term mortality.